-+ 0.00%
-+ 0.00%
-+ 0.00%

ERNEXA THERAPEUTICS REPORTS STRONG QUARTERLY PERFORMANCE, HIGHLIGHTING OPERATIONAL EXECUTION AND PROGRESS TOWARD FIRST-IN-HUMAN CELL THERAPY TRIALS

Reuters·11/10/2025 13:35:00

Please log in to view news